Advertisement
Screener

ARDELYX, INC. (ARDX) EBITDA

ARDELYX, INC. (ARDX) EBITDA

  • 2026-06-30: Basis Reported; EBITDA -$11.82M*; Operating income -$12.43M; Depreciation and amortization $604.00K*.
  • 2026-03-31: Basis Reported; EBITDA -$31.88M; Operating income (m); Depreciation and amortization (m).
  • 2025-12-31: Basis Reported; EBITDA $6.02M; Operating income (m); Depreciation and amortization (m).
  • 2025-09-30: Basis Reported; EBITDA $5.57M*; Operating income $4.67M; Depreciation and amortization $905.00K*.

Complete source-backed ebitda history.

Available history
2020-12-31 to 2026-03-31
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported-$11.82M*-$12.43M$604.00K*$120.88M-9.78%*$13.00K*-$6.40M*$5.76M$26.10M$101.44M$110.00K
2026-03-31Reported-$31.88M(m)(m)(m)-33.74%$69.00K-$32.24M$4.81M$20.19M$102.27M$8.00K
2025-12-31Reported$6.02M(m)(m)(m)4.81%(m)(m)(m)(m)(m)(m)
2025-09-30Reported$5.57M*$4.67M$905.00K*$110.33M5.05%*$156.00K*$365.00K*$3.98M$18.07M$83.61M$102.00K
2025-06-30Reported-$13.76M*-$14.39M$631.00K*$97.66M-14.09%*$650.00K*-$25.34M*$12.40M$15.67M$83.99M$1.00K
2025-03-31Reported-$35.75M(m)(m)(m)-48.23%$325.00K-$38.46M$12.30M$14.94M$83.22M$859.00K
2024-12-31Reported$8.64M(m)(m)(m)7.44%(m)(m)(m)(m)(m)(m)
2024-09-30Reported$2.78M*$2.23M$544.00K*$98.24M2.83%*$137.00K*$501.00K*$15.73M$15.31M$64.97M$43.00K
2024-06-30Reported-$13.06M*-$13.63M$569.00K*$73.22M-17.84%*$131.00K*-$19.40M*$9.44M$12.76M$64.65M$67.00K
2024-03-31Reported-$24.24M(m)(m)(m)-52.68%$150.00K-$35.72M$7.13M$10.58M$52.99M$121.00K
2023-12-31Reported-$27.62M(m)(m)(m)-80.39%(m)(m)(m)(m)(m)(m)
2023-09-30Reported$7.69M*$7.40M$291.00K*$56.39M13.64%*$194.00K*-$21.47M*$7.69M$8.64M$32.66M$200.00K
2023-06-30Reported-$15.98M*-$16.62M$642.00K*$22.33M-71.56%*$93.00K*-$14.74M*$3.49M$8.28M$27.19M$0.00
2023-03-31Reported-$26.07M(m)(m)(m)-229.28%$14.00K-$44.80M$1.54M$9.09M$26.80M$14.00K
2022-12-31Reported$12.27M(m)(m)(m)27.77%(m)(m)(m)(m)(m)(m)
2022-09-30Reported-$21.60M*-$21.88M$279.00K*$4.99M-433.23%*$0.00*-$25.43M*$732.00K$7.47M$18.67M$0.00
2022-06-30Reported-$25.94M*-$26.21M$275.00K*$2.53M-1026.92%*$0.00*-$31.28M*$138.00K$9.74M$18.86M$6.00K
2022-03-31Reported-$27.34M(m)(m)(m)-5842.74%$0.00-$27.62M(m)$8.85M$19.34M$2.00K
2021-12-31Reported-$34.78M(m)(m)(m)-3379.79%(m)(m)(m)(m)(m)(m)
2021-09-30Reported(m)-$42.24M(m)$1.17M(m)$445.00K*-$34.59M*(m)$23.70M$19.71M$1.00K
2021-06-30Reported(m)-$44.83M(m)$1.31M(m)$739.00K*-$34.28M*(m)$26.02M$20.12M$2.00K
2021-03-31Reported(m)-$32.01M(m)$6.58M(m)$778.00K-$44.22M(m)$20.46M$17.13M$1.00K
2020-09-30Reported(m)-$17.16M(m)$2.71M(m)$49.00K*-$19.88M*(m)$12.24M(m)$0.00
2020-06-30Reported(m)-$24.21M(m)$1.84M(m)$0.00*-$19.02M*(m)$18.86M(m)$0.00
2020-03-31Reported(m)-$21.77M(m)$1.21M(m)$25.00K-$24.95M(m)$15.84M(m)$0.00
2019-09-30Reported(m)-$22.09M(m)$3.01M(m)$114.00K*-$20.61M*(m)$17.58M(m)$301.00K
2019-06-30Reported(m)-$24.83M(m)$18.00K(m)$46.00K*-$27.82M*(m)$19.48M(m)$0.00*
2019-03-31Reported(m)-$25.50M(m)(m)(m)$165.00K-$16.91M(m)$20.38M(m)$2.00K
2018-09-30Reported(m)-$23.73M(m)$172.00K(m)-$31.00K*-$27.02M*(m)$17.94M(m)$0.00*
2018-06-30Reported(m)-$22.15M(m)$30.00K(m)$0.00*-$18.02M*(m)$16.05M(m)$2.00K
2018-03-31Reported(m)-$17.68M(m)$2.32M(m)$55.00K-$6.80M(m)$13.35M(m)$4.00K
2017-09-30Reported(m)-$21.23M(m)(m)(m)$420.00K*-$19.24M*(m)$15.37M(m)$0.00
2017-06-30Reported(m)-$26.42M(m)(m)(m)$789.00K*-$23.89M*(m)$20.57M(m)$0.00
2017-03-31Reported(m)-$28.43M(m)(m)(m)$1.12M-$26.76M(m)$22.39M(m)$0.00
2016-09-30Reported(m)-$29.20M(m)(m)(m)$1.61M*(m)(m)$24.86M(m)$0.00
2016-06-30Reported(m)-$28.69M(m)(m)(m)$295.00K*(m)(m)$23.84M(m)$0.00
2016-03-31Reported(m)-$23.53M(m)(m)(m)$200.00K(m)(m)$19.25M(m)$0.00
2015-09-30Reported(m)-$18.08M(m)(m)(m)$680.00K*(m)(m)$14.71M(m)-$30.00K
2015-06-30Reported(m)$9.06M(m)(m)(m)$1.26M*(m)(m)$6.20M(m)$0.00
2015-03-31Reported(m)-$3.49M(m)(m)(m)$1.05M(m)(m)$6.20M(m)$0.00
2014-09-30Reported(m)$81.00K(m)(m)(m)$88.00K*(m)(m)$5.69M(m)(m)
2014-06-30Reported(m)$2.75M(m)(m)(m)$642.00K*(m)(m)$5.18M(m)$0.00
2014-03-31Reported(m)-$464.00K(m)(m)(m)$94.00K(m)(m)$7.64M(m)$0.00
2013-09-30Reported(m)-$886.00K(m)(m)(m)$21.00K*(m)(m)$6.58M(m)$35.00K
2013-06-30Reported(m)-$851.00K(m)(m)(m)(m)(m)(m)$7.23M(m)$36.00K

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-31Reported-$37.92M(m)(m)(m)-9.31%$1.49M-$42.48M$39.54M$71.53M$337.23M$969.00K
2024-12-31Reported-$25.89M(m)(m)(m)-7.76%$1.01M-$44.81M$50.56M$52.32M$258.69M$266.00K
2023-12-31Reported-$61.98M(m)(m)(m)-49.80%$344.00K-$89.72M$17.80M$35.54M$134.40M$547.00K
2022-12-31Reported-$62.62M(m)(m)(m)-120.05%$55.00K-$70.04M$4.12M$35.20M$76.60M$8.00K
2021-12-31Reported-$151.54M(m)(m)(m)-1500.83%$1.87M-$152.55M$1.00M$91.14M$72.30M$4.00K
2020-12-31Reported-$88.24M(m)(m)(m)-1165.49%$324.00K-$81.44M(m)$65.05M(m)$2.00K
2019-12-31Reported(m)-$91.26M(m)$5.28M(m)$325.00K-$76.48M(m)$71.68M(m)$303.00K
2018-12-31Reported(m)-$90.95M(m)$2.61M(m)$311.00K-$70.27M(m)$69.37M(m)$4.00K
2017-12-31Reported(m)-$65.11M(m)$42.00M(m)$2.35M-$65.19M(m)$75.48M(m)$1.18M
2016-12-31Reported(m)-$112.89M(m)(m)(m)$4.87M-$92.53M(m)$94.16M(m)(m)
2015-12-31Reported(m)-$29.39M(m)(m)(m)$3.45M-$71.84M(m)$39.88M(m)-$29.00K
2014-12-31Reported(m)-$1.56M(m)(m)(m)$1.86M(m)(m)$25.90M(m)$67.00K
2013-12-31Reported(m)-$2.87M(m)(m)(m)$278.00K(m)(m)$28.09M(m)$141.00K
2012-12-31Reported(m)-$8.80M(m)(m)(m)$128.00K(m)(m)$10.18M(m)(m)

Similar stocks

Stock NameCountryMarket CapPE Ratio
Avalo Therapeutics, Inc. (AVTX)United States$0.842B-9.74
Immix Biopharma, Inc. (IMMX)United States$0.837B-18.44
Cryoport, Inc. (CYRX)United States$0.881B-21.29
Theravance Biopharma, Inc. (TBPH)$0.885B16.40
Obsidian Therapeutics, Inc. (OBX)United States$0.829B
LEXICON PHARMACEUTICALS, INC. (LXRX)United States$0.823B-17.48
RIGEL PHARMACEUTICALS INC (RIGL)United States$0.893B2.25
GYRE THERAPEUTICS, INC. (GYRE)United States$0.818B-24.71
Apnimed, Inc. (APMD)United States$0.899B
GERON CORP (GERN)United States$0.803B-12.14